Best 7 Cardiovascular and Blood Pressure Medications for Dogs in the UK — 2026 Guide
Published on Wednesday, 25 February 2026
When a dog is diagnosed with heart disease, veterinary teams in the United Kingdom commonly use combination drug protocols to control symptoms, reduce fluid overload, and slow disease progression. This category covers prescription cardiovascular and blood pressure medications for dogs, including ACE inhibitors, diuretics, inotropic agents, aldosterone antagonists, and other adjunct vasodilators. British veterinary cardiologists and general practitioners tailor multi-drug plans to each dog's condition, disease stage, and overall health. UK owners favor these therapies because they are supported by clear clinical pathways, available through local veterinary practices and licensed pharmacies, and increasingly affordable thanks to generic options. Palatable or flavoured formulations improve owner adherence, and established monitoring schedules let vets safely adjust doses. This page highlights the most widely used, evidence-backed prescription options for canine cardiac care in the UK and explains why they remain popular with both clinicians and owners.
Top Picks Summary
- Vetmedin (Pimobendan) 1.25mg, 2.5mg, 5mg, 10mg Chewable Tablets
- Fortekor (Benazepril) 2.5mg, 5mg, 20mg Flavoured Tablets
- Frusedale (Furosemide) 40mg Tablets
- Cardalis (Benazepril/Spironolactone) Small, Medium, Large Flavoured Tablets
- Prilactone (Spironolactone) 10mg, 40mg, 80mg Palatable Tablets
- Isachem (Isosorbide Mononitrate) 10mg, 20mg Tablets
- Enacard (Enalapril) 1mg, 2.5mg, 5mg, 10mg, 20mg Tablets
Fortekor (Benazepril) 2.5mg, 5mg, 20mg Flavoured Tablets
Fortekor holds a leading position due to its established ACE‑inhibitor profile delivered in palatable, multi‑strength tablets that support adherence and predictable pharmacokinetics. Compared with Frusedale's acute diuretic role, Prilactone's potassium‑sparing profile and Isachem's vasodilator action, Fortekor offers a cost‑effective, long‑term cardiovascular management option with strong manufacturer support — a practical choice for the search topic "undefined".
Frusedale (Furosemide) 40mg Tablets
Frusedale is the market leader for rapid fluid removal thanks to reliable 40mg dosing and typically lower generic pricing that makes it the go‑to for acute decongestion. Technically superior for pulmonary edema and volume overload versus Fortekor, Prilactone and Isachem, it delivers immediate clinical and financial advantages in short‑term care scenarios relevant to the search topic "undefined".
Cardalis (Benazepril/Spironolactone) Small, Medium, Large Flavoured Tablets
Cardalis earns a top spot in this 2025 British Guide because its fixed‑dose benazepril/spironolactone combination reduces pill burden and improves owner adherence in guideline‑based multi‑drug protocols. Technically and financially, the combination tablet can lower dispensing complexity and total drug cost versus prescribing separate benazepril and spironolactone products, and its flavoured formulations support administration in reluctant patients. In practices that prioritise simplified regimens for chronic management, Cardalis is often preferred over using two separate agents from this list despite less granular dosing flexibility.
Prilactone (Spironolactone) 10mg, 40mg, 80mg Palatable Tablets
Prilactone is recognized for its flexible, palatable spironolactone formulations that improve long‑term adherence and provide potassium‑sparing, renoprotective benefits. Financially and clinically it can reduce overall diuretic dose requirements (and associated costs) when used alongside Frusedale, and it uniquely complements ACE inhibition from Fortekor and the vasodilator profile of Isachem within the broader 'undefined' treatment landscape.
Isachem (Isosorbide Mononitrate) 10mg, 20mg Tablets
Isachem stands out for predictable anti‑anginal vasodilation with straightforward dosing (10mg and 20mg) and a low monitoring burden that appeals in both acute and chronic settings. While it does not replace the antihypertensive effects of Fortekor or the diuretic potency of Frusedale, its stable pharmacology and typically favorable generic pricing make it a pragmatic, low‑overhead option for the search topic "undefined".
Enacard (Enalapril) 1mg, 2.5mg, 5mg, 10mg, 20mg Tablets
Enacard is presented as a versatile enalapril option in the 2025 British Guide thanks to its wide dose range and long clinical history in canine cardiac care, making it a cost‑effective alternative to other ACE inhibitors for some patients. Compared with Fortekor, Enacard’s broader low‑dose increments can offer finer titration in sensitive patients, while still integrating effectively into vet‑reviewed combination regimens with pimobendan and diuretics. From a practice perspective, Enacard’s generic positioning often translates to lower per‑tablet cost for long‑term maintenance therapy.
How these medicines help — evidence and practical considerations
Clinical research and veterinary guidelines explain how the main drug classes work together to stabilise dogs with cardiac disease and improve quality of life. Trials and consensus guidance support the selective use of inotropes, diuretics, ACE inhibitors, and aldosterone antagonists in combination, with therapy tailored and monitored by a veterinary team. Below are approachable summaries of the scientific rationale and practical monitoring steps recommended in UK practice.
Pimobendan (inotropic agent and vasodilator) has been shown in major trials to improve clinical signs and outcomes in dogs with systolic dysfunction or congestive heart failure; it is commonly recommended by cardiology specialists as part of multi-drug protocols.
ACE inhibitors such as benazepril and enalapril reduce harmful neurohormonal activation and afterload; they are widely used to support cardiac function and slow disease progression when paired with other agents.
Loop diuretics like furosemide rapidly relieve fluid accumulation in congestive heart failure. They are essential for acute control of pulmonary edema and for long-term symptom management when dosed and monitored carefully.
Aldosterone antagonists such as spironolactone provide additional protection against aldosterone-driven fluid retention and cardiac remodeling; clinical practice and emerging studies support their role as adjunctive therapy.
Nitrate derivatives such as isosorbide mononitrate are sometimes used as adjunct vasodilators in specific cases to reduce preload and relieve symptoms when other options are limited.
Safety and monitoring: regular checks of kidney function, electrolytes, body weight, appetite, and blood pressure are standard. Dose adjustments are made based on clinical response and laboratory results to balance effectiveness with side-effect risk.
Guidance sources: current practice in the UK aligns with recommendations from veterinary cardiology specialists and national professional bodies, and peer-reviewed clinical trials inform drug selection and combination strategies.
Frequently Asked Questions
Which dog heart med should I start with Fortekor?
Choose Fortekor (Benazepril) for systemic hypertension and canine heart failure under veterinary supervision; it’s available as flavoured tablets in 2.5mg, 5mg and 20mg strengths and has a 4.7 average rating.
How does Vetmedin pimobendan dosing work for CHF?
Vetmedin chewable pimobendan comes in 1.25mg, 2.5mg, 5mg and 10mg strengths so vets can titrate dose; it contains pimobendan inodilator to improve cardiac output in canine CHF, with an average rating of 4.6.
Is Frusedale 40mg better value than Fortekor?
Frusedale (Furosemide) 40mg tablets are described as “market leader” for rapid fluid removal and typically have lower generic pricing; you get furosemide 40mg for diuresis, which helps reduce fluid overload, with a 4.4 average rating.
Does Frusedale need monitoring for hydration and electrolytes?
Yes—Frusedale (Furosemide) 40mg tablets require monitoring of hydration and electrolytes because increased urine output can cause potential electrolyte loss; it’s rated 4.4 and is used for fluid removal in heart failure or oedema.
Conclusion
In the UK, a structured, multi-drug approach to canine cardiac care offers owners and vets predictable, evidence-aligned options that can improve quality of life and help manage progressive disease. The main products featured here — Vetmedin (Pimobendan) 1.25mg, 2.5mg, 5mg, 10mg Chewable Tablets, Fortekor (Benazepril) 2.5mg, 5mg, 20mg Flavoured Tablets, Frusedale (Furosemide) 40mg Tablets, Cardalis (Benazepril/Spironolactone) Small, Medium, Large Flavoured Tablets, Prilactone (Spironolactone) 10mg, 40mg, 80mg Palatable Tablets, Isachem (Isosorbide Mononitrate) 10mg, 20mg Tablets, Enacard (Enalapril) 1mg, 2.5mg, 5mg, 10mg, 20mg Tablets — are those most commonly used in combination protocols across UK practices. While all have important roles, Vetmedin (Pimobendan) is often the single most impactful medicine for many dogs with systolic dysfunction or congestive heart failure and is frequently a core component of multi-drug regimens. We hope you found the guidance and product summaries you were looking for. If you want to narrow results by dose, formulation, or price, or to explore alternative therapies and monitoring advice, you can refine or expand your search using the site search.